ANTIVIRAL ACTIVITY AND SAFETY OF TMC435 COMBINED WITH PEGINTERFERON ALPHA-2A AND RIBAVIRIN IN PATIENTS WITH GENOTYPE 1 HEPATITIS C INFECTION WHO FAILED PREVIOUS IFN-BASED THERAPY

P Marcellin; H Reesink; T Berg; M Cramp; R Flisiak; Vlierberghe H Van; R Verloes; O Lenz; M Peeters; V Sekar; Smedt G De

doi:10.1016/S0168-8278(09)61060-6

ANTIVIRAL ACTIVITY AND SAFETY OF TMC435 COMBINED WITH PEGINTERFERON ALPHA-2A AND RIBAVIRIN IN PATIENTS WITH GENOTYPE 1 HEPATITIS C INFECTION WHO FAILED PREVIOUS IFN-BASED THERAPY

P Marcellin, H Reesink, T Berg, M Cramp, R Flisiak, Vlierberghe H Van, R Verloes, O Lenz, M Peeters, V Sekar, Smedt G De

Peninsula Medical School

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	S385-S385
Number of pages	0
Journal	Journal of Hepatology
Volume	50
Issue number	0
DOIs	https://doi.org/10.1016/S0168-8278(09)61060-6
Publication status	Published - 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0168-8278(09)61060-6

Cite this

Marcellin, P., Reesink, H., Berg, T., Cramp, M., Flisiak, R., Van, V. H., Verloes, R., Lenz, O., Peeters, M., Sekar, V., & De, S. G. (2009). ANTIVIRAL ACTIVITY AND SAFETY OF TMC435 COMBINED WITH PEGINTERFERON ALPHA-2A AND RIBAVIRIN IN PATIENTS WITH GENOTYPE 1 HEPATITIS C INFECTION WHO FAILED PREVIOUS IFN-BASED THERAPY. Journal of Hepatology, 50(0), S385-S385. https://doi.org/10.1016/S0168-8278(09)61060-6

@article{5768a347184b418389537b5279a8766b,

title = "ANTIVIRAL ACTIVITY AND SAFETY OF TMC435 COMBINED WITH PEGINTERFERON ALPHA-2A AND RIBAVIRIN IN PATIENTS WITH GENOTYPE 1 HEPATITIS C INFECTION WHO FAILED PREVIOUS IFN-BASED THERAPY",

author = "P Marcellin and H Reesink and T Berg and M Cramp and R Flisiak and Van, \{Vlierberghe H\} and R Verloes and O Lenz and M Peeters and V Sekar and De, \{Smedt G\}",

year = "2009",

doi = "10.1016/S0168-8278(09)61060-6",

language = "English",

volume = "50",

pages = "S385--S385",

journal = "Journal of Hepatology",

issn = "0168-8278",

publisher = "Elsevier B.V.",

number = "0",

}

Marcellin, P, Reesink, H, Berg, T, Cramp, M, Flisiak, R, Van, VH, Verloes, R, Lenz, O, Peeters, M, Sekar, V & De, SG 2009, 'ANTIVIRAL ACTIVITY AND SAFETY OF TMC435 COMBINED WITH PEGINTERFERON ALPHA-2A AND RIBAVIRIN IN PATIENTS WITH GENOTYPE 1 HEPATITIS C INFECTION WHO FAILED PREVIOUS IFN-BASED THERAPY', Journal of Hepatology, vol. 50, no. 0, pp. S385-S385. https://doi.org/10.1016/S0168-8278(09)61060-6

TY - JOUR

T1 - ANTIVIRAL ACTIVITY AND SAFETY OF TMC435 COMBINED WITH PEGINTERFERON ALPHA-2A AND RIBAVIRIN IN PATIENTS WITH GENOTYPE 1 HEPATITIS C INFECTION WHO FAILED PREVIOUS IFN-BASED THERAPY

AU - Marcellin, P

AU - Reesink, H

AU - Berg, T

AU - Cramp, M

AU - Flisiak, R

AU - Van, Vlierberghe H

AU - Verloes, R

AU - Lenz, O

AU - Peeters, M

AU - Sekar, V

AU - De, Smedt G

PY - 2009

Y1 - 2009

U2 - 10.1016/S0168-8278(09)61060-6

DO - 10.1016/S0168-8278(09)61060-6

M3 - Article

SN - 0168-8278

VL - 50

SP - S385-S385

JO - Journal of Hepatology

JF - Journal of Hepatology

IS - 0

ER -